analysis of the early molecular events associated with it. To resolve them we need multiple approaches against lung cancer The mouse telomerase holoenzyme, which synthesizes telthat encompass epidemiological and clinical data as well as omeric DNA de novo, is a ribonucleoprotein complex that adequate in vitro and/or in vivo experimental systems. includes the mouse telomerase RNA component (mTERC), Among many animal models available for the analysis of mouse telomerase-associated protein (mTEP1) and mouse human lung adenocarcinoma, urethane-induced lung tumoritelomerase reverse transcriptase (mTERT). To determine genesis in A/J mice is thought to be one of the most useful the role of telomerase in urethane-induced lung tumoribecause of its faithful reproducibility, histological similarity genesis in A/J mice we examined telomerase activity and and time-dependent progression from hyperplasia through the expression of each telomerase subunit in 20 tumor adenoma and eventually to adenocarcinoma (2,3). This model samples, harvested at 16, 28, 40 and 50 weeks after urethane is also important because atypical adenomatous hyperplasia, treatment. The telomeric repeat amplification protocol which is histologically similar to hyperplasia/adenoma in the assay showed that statistically significant telomerase activa-A/J mouse model, has been categorized as a premalignant tion occurred both early and late in tumorigenesis. Semilesion of bronchioloalveolar carcinoma in a new histological quantitative reverse transcription-polymerase chain reacclassification of human lung cancer (4). Furthermore, mouse tion analysis revealed that mRNA expression levels of lung epithelial cells have been shown to accumulate a number mTEP1 and mTERT were up-regulated during tumor proof genetic changes sequentially, involving oncogenes and gression, while mTERC expression was not significantly tumor suppressor genes, to develop overt lung cancer during different between tumors and normal lung. We further the multistage process of carcinogenesis and human lung examined mTEP1 protein expression in normal lung tissue cancer arises through a similar process (3,5). Among such and lung tumors; western blot analysis showed preferential genetic changes examined so far, K-ras and p53 are frequent expression of mTEP1 protein in lung tumors compared targets for developing lung adenocarcinomas in urethanewith normal lung and immunohistochemistry revealed that treated A/J mice as well as in human (5,6). Based on such a majority of the adenoma cells were positively stained in histological and molecular similarities, further elucidation the nucleus, whereas only a few of the adjacent normal of the genetic and/or biochemical aspects of mouse lung alveolar cells were immunoreactive. In addition, we investicarcinogenesis would enable us to understand the pathogenesis gated DNAs of the 20 tumor samples by single strand of human lung cancer and to utilize this model to evaluate conformation polymorphism and sequencing analyses to molecular and pharmacological interventions, which may prove examine whether alterations of the p53 gene in exons 5-8 efficacious in treatment and possible prevention. were associated with telomerase activity. Although we It is becoming clearer that one of the key processes of found one nonsense, two missense, two silent and one neoplasia is characterized by activation of telomerase, a ribosimultaneous double mutation at different codons in six late nucleoprotein enzyme complex that adds telomeric repeats to stage tumors, there was no apparent correlation between the ends of replicating chromosomes, the telomere (7). Howtelomerase activity and p53 mutations. Collectively, these ever, the role of telomerase in human lung carcinogenesis has results suggest that mTEP1 as well as mTERT may be not been fully clarified to date. Thus, using a well-established involved in the regulation of telomerase activity and that A/J mouse model we examined telomerase activity and telomerase activation may contribute to lung tumorigenesis expression of the three major subunits of telomerase, mouse in A/J mice independently of p53 gene alterations.
telomerase reverse transcriptase (mTERT), mouse telomeraseassociated protein (mTEP1) and mouse telomerase RNA component (mTERC). Furthermore, to determine whether genetic alterations of the p53 gene were associated with which might contribute to carcinogenesis independently of the p53 alteration, and that mTEP1 as well as mTERT may play an important role in the regulation of telomerase activity. DNA was prepared from each CHAPS cell lysate using a standard phenol/ which works as an internal PCR control for each TRAP assay. TRAP assay chloroform extraction method (10) and subjected to nested or hemi-nested products were separated by 12.5% PAGE, dried and autoradiographed. The PCR amplification to detect p53 mutations between exons 5 and 8, including intensity of each TRAP assay product and ITAS was calculated by measuring the exon-intron boundaries, as previously described (5). The PCR products the generated bands using NIH Image v.1.61, which is a powerful image labeled with [α-32 P]dCTP were diluted with formamide dye solution and processing application and can be downloaded from the NIH Image ftp site electrophoresed on 6% polyacrylamide gels. No PCR products were detected (rsbweb.nih.gov). This application can simultaneously measure density and in an all CHAPS control after two rounds of amplification. Aberrant bands spatial data from a properly calibrated image. The quantitation of telomerase were reamplified with the same primer set and the purified PCR products activity was estimated by the following formula: relative specific activity of were sequenced using an Applied Biosystems model 377 DNA sequencer telomerase ϭ the intensity of each TRAP assay product Ϭ the intensity of (Perkin-Elmer Cetus, Norwalk, CT) as described previously (11). each ITAS. As a positive control, 0.25 and 0.5 µg cell extract from human
Materials and methods

Lung tumor induction
Statistical analysis lung cancer cell line NIH H1299 were used; as a negative control, 2 µl of lysis buffer without any cell extract was used.
Associations between telomerase activities and tumor development were evaluated using a non-parametric statistical method. All statistical tests were
Reverse transcription-polymerase chain reaction (RT-PCR)
conducted at the two-sided 0.05 level of significance. Total cellular RNAs were isolated from the normal lung of untreated mice, pooled small tumor samples and middle sized individual tumors of urethaneResults treated mice by a single-step guanidine isothiocyanate method, using Isogen (Nippongene, Tokyo, Japan), and were treated with DNase I (Takara Shuzo Table I ). The level of telomerase activity per 2 µg cell extract blotted as described previously (8) . Immunoblots were detected using an ECL protein was very low in normal lung tissues compared with chemiluminescence system (Amersham, Little Chalfont, UK) according to the manufacturer's instructions and exposed on Amersham Hyperfilm. The rabbit the high activity of either 0.25 or 0.5 µg extract derived from polyclonal antibody specific for mTEP1 was generated against recombinant NCI-H1299, a human lung carcinoma cell line previously mTEP1 protein.
Activation of telomerase in urethane-induced lung tumorigen-
shown to express high telomerase activity. Although there (Table I ; P Ͻ 0.05, normal lung versus lung tumors at avidin-biotin-peroxidase complex method as described previously (9) . Nuclear staining was done with methyl green.
16, 28, 40 or 50 weeks). Among all tumors examined the average level of telomerase activity of the 50 week tumors was significantly higher than that of the other tumors (P Ͻ 0.05, 50 week tumors versus 16-40 week tumors), indicating that telomerase activities might be elevated in both the early and late stages of tumorigenesis. Heat inactivation or RNase treatment of each sample abolished telomerase activity, indicating that TRAP products were attributable to telomerase (data not shown). mTERC. We collected another set of tumor samples at 16, 28, 40 and 50 weeks after urethane treatment and normal lung tissues of untreated mice at 20 and 55 weeks of age, extracted of β-actin mRNA was done as a control to normalize the RNAs and performed semi-quantitative RT-PCR (Figure 2) . amount of RNAs among these samples. Expression of mTEP1 mRNA was weak in normal lung tissue mTEP1 protein expression in normal lung and lung tumors but increased in all lung tumors tested, indicating that mTEP1 is up-regulated at an early stage of tumorigenesis. Up-regulation
To confirm preferential expression of mTEP1 in lung tumors compared with normal lung tissue we performed western blot of mTERT mRNA expression was also observed in tumors, suggesting that mTEP1 as well as mTERT might be involved in analyses using a polyclonal antibody specific for mTEP1 protein.
As shown in Figure 3A , mTEP1 protein expression the regulation of telomerase activity. In contrast, the expression level of mTERC were almost the same in normal lung tissue was up-regulated at a similar level in both 16 and 40 week lung tumors compared with normal lung tissue, which was and lung tumors at different time points, suggesting that telomerase activity may not be regulated by expression of consistent with their mRNA expression levels. Further investigations of the expression and location of mTEP1 protein by mTERC in the urethane-induced lung tumor model. RT-PCR TRAP assay and performed PCR-SSCP analysis for p53 mutations (Figure 4 ). Six tumors (two at 40 weeks and four at 50 weeks after treatment) showed six altered bands with different mobilities from those of normal lung in exons 5 and 8, but no alterations were observed in exons 6 and 7. These six tumors were further analyzed by sequencing (Table I) . We found one nonsense, two missense and two silent and one double mutation at different codons. We did not distinguish whether these mutations accompanied wild-type allele loss, due to inevitable contamination by normal cell DNAs. Although p53 mutations occurred in the late stage during tumor progression, no apparent correlation was found between the level of telomerase activity and the p53 gene alteration, suggesting that p53 alterations might not have an effect on telomerase activation.
Discussion
In this study we found that telomerase activity was elevated at the early stage and further increased at the late stage during the progression of tumorigenesis with statistical significance, of tumor progression (14) . The different timing of telomerase activation during tumor progression may depend on the tissue immunohistochemical analysis indicated that only a few normal analyzed and the mouse model used. alveolar cells were immunoreactive, whereas the majority of Although we observed statistically higher levels of telomerthe 40 week adenoma cells showed positive nuclear staining ase activity in lung tumors than in normal lung tissue, it ( Figure 3B and C) . The same result was obtained in the 16 is unclear how telomerase activation contributes to tumor week adenomas (data not shown). Association of up-regulation development in our model. Indeed, telomerase activation does of mTEP1 expression with telomerase activation at an early not seem to be essential for tumor development, since tumors stage of tumor progression suggested that mTEP1 might be were formed in telomerase-defective mTERC knockout mice one of the key regulators of telomerase activity in this model. (15) . In this regard it is noteworthy that in double knockout Association of telomerase activation and p53 gene alteration mice for both mTERC and the tumor suppressor genes p16/ p19ARF, tumors developed with~50% incidence compared Since we previously found that p53 mutations between exons 5 and 8 occurred~40 weeks after urethane treatment in this with that in p16/p19ARF knockout mouse (16) . Moreover, restoration of mTERC into MEF cells significantly restored model, we hypothesized that p53 mutations might affect activation of telomerase at a late stage of tumor progression.
oncogenic potential (16) , suggesting that activation of telomerase may play an important role in promoting tumor progression. To test this we isolated DNAs from 20 cell lysates used for TEP1, the mammalian homolog of Tetrahymena p80 telowould be necessary to examine the precise tissue distribution and localization of mTERC in murine tissues. Furthermore, a merase protein, has been shown to interact specifically with TERC and TERT. TEP1 contains repeated sequences in the comparative study by in situ hybridization or immunohistoligical analysis of all three telomerase components and the C-terminus, referred to as the WD-40 motif, which has been suggested to function in protein-protein interactions (17, 18) .
in situ version of the TRAP assay (27) may determine which is the critical component for regulation of telomerase activity. Indeed, it has been reported that TEP1 is a shared component of the telomerase complex and the vaults (19) . The vaults are
Since we previously reported that p53 mutation frequently occurs as a late event in urethane-induced lung tumorigenesis large cytoplasmic ribonucleoprotein complexes of undetermined function. Furthermore, it has also been reported that (5) and because the p53 and/or Rb tumor suppressor pathways have been implicated as crucial for the checkpoint responses the region close to the N-terminus of hTEP1 and the Cterminal region of p53 interact in vitro (20) . However, the of telomere length (28), we hypothesized that inactivation of the p53 gene might affect telomerase activity. To test this we function of TEP1 has not yet been elucidated clearly, even in telomere regulation. In our study we found that both mTEP1 upexamined p53 alterations in exons 5-8, where the vast majority of p53 mutations occur (6) . We found one nonsense, two regulation and telomerase activation occurred simultaneously in an early stage of tumorigenesis. This implies that mTEP1 missense, two silent and one simultaneous double mutation at different codons in six tumors at the late stage, but found no may participate in the regulatory mechanisms that control telomerase activity. Moreover, the role of TEP1 in the regulaapparent correlation between the p53 mutations and the level of telomerase activity, although there may be some p53 tion of telomerase may be different between human and mouse, since hTEP1 mRNA has been found to be constitutively mutations outside exons 5-8. However, since it has been reported that murine fibroblast cell lines established from p53 ϩ/ϩ expressed in normal lung and lung cancer (21) .
In human lung cancer the hTERT expression level is well and p53 -/-mice expressed telomerase regardless of the p53 status of their tissue of origin (29), telomerase activation and correlated with telomerase activity and is considered as a surrogate marker for it (21, 22) . In the A/J mouse lung tumor p53 inactivation in the A/J mouse lung tumor model may be independent and cooperating molecular events that occur model the mTERT mRNA expression level was also upregulated in tumors compared with normal lung tissue, sugduring the multistage process of carcinogenesis.
In human non-small cell lung cancer several groups have gesting that mTERT might be involved in the regulation of telomerase activity. However, there was not so much difference shown statistically significant associations between mutant p53 expression and telomerase activity (30-32), while another in mTERT mRNA expression among tumors during progression, while telomerase activity in the late stage of tumorigenesis study has not found any significant association (33). Although additional studies will be needed to draw a definitive concluwas further increased. This suggests that other regulatory mechanisms, such as loss of telomerase inhibitors, may be sion, the p53 gene may have different roles in the regulation of telomerase activity in human and mouse. involved in telomerase activation.
mTERC has been shown to be a possible regulator of In the present study we have demonstrated the significance of telomerase activation during lung tumor progression in the telomerase activity in mouse skin and pancreatic cancer models, mTERC being up-regulated in the hyperproliferative stages A/J mouse and the involvement of mTEP1 and mTERT in the regulation of telomerase activity. With further studies of of progression before telomerase activity is increased (12) . However, mTERC might not affect telomerase activity in the telomerase activation and telomere regulation in murine lung tumorigenesis, the commonalities and distinctions between murine lung, since we found that mTERC was expressed at the same level in normal lung and lung tumors. Rather, as human and mouse may provide an integrated understanding of the complex genetic events underlying human lung cancer hTERC and hTERT were shown to be able to reconstitute telomerase activity in vitro with properties similar to those of development. native telomerase (23), expression of mTERC and mTERT in normal lung tissue may merely reflect the basal level of Acknowledgements intrinsic telomerase activity.
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The tissue distribution of hTERC has been examined using to be expressed in most somatic tissues, although its expression level was much lower than in cancer and gonads (24). Another References study, using RT-PCR, has reported that hTERC was expressed northern blot analysis. On the other hand, the tissue distribution (1996) Ki-ras and p53 mutations are early and late events, respectively, of mTERC has been analysed by northern blot analysis and in urethane-induced pulmonary carcinogenesis in A/J mice. Mol. Carcinog., 17, 217-223.
RT-PCR but not by in situ hybridization. This latter technique
